Hi. I'm very interested but I have some questions if you don't mind: -How much will each application cost? -Will it be covered by insurance? -What are your revenue goals for the next 5 years? This is key for me as it will give me an idea of the company's potential and what kin...

Hello Leonardo All good questions. The cost will of course vary with the location and size of the lesion but we expect the charge approximately $5,000 per hip. Individual vertebrae would be less if multiple vertebrae are treated at once. OsNovum is classified as a bone graft and it will be covered as a bone graft. Virtually any insurance company would be happy to pay $5,000 to prevent a hip fracture. The plane is taxiing so I will complete my response latter.

Cpñica okay, vacations from back surgery what can I be rewarded from medical malpractice

Cpnica? The vast majority of back surgeries are performed as a result of disk pathology. OsNovum has nothing to do with disk or cartilage pathology.

I hope you can finish your answer before the early bird terms end, I need the revenue goals to make my decision.

Hello Leonardo Please read the following and get back to me. I just recently posted this to our investors. All the best,Financial Projections To: OsNovum Investors Here at OsNovum/SteinerBio we need to deal with facts. When treating a patient, you must put aside any bias or dogma and honestly critique how your patient responds to therapy. You cannot let what you want to happen cloud the reality of what is actually happening. This is ingrained in us and as a result we cannot look at business a...

Thanks for that. I was just hoping for your personal revenue goals, what numbers you are aiming to reach year by year. What's the margin on a $5,000 application? Can You disclose that?

Revenue goals We are wrapping up the FDA submission at this time and will hopefully submit in about 3 months. We could get approval in 6 months to a year and then we go to market. The costs associated with osteoporotic fractures is immense and that is related to our income. Let’s limit our discussion to about vertebral osteoporotic fractures to get a sense of the market and revenue stream. There are approximately 700,000 vertebral compression fractures per year in the US. There are currently ...

Hello Dr. Steiner Iam interested in investing and would like to know what distinguishes OsNovum from other treatments in the market such as Teriparatide(Forteo), Abaloparatide (Tymlos), Romosozumab (Evenity). In other words, what is your competitive advantage? Thanks

Hello SalehThe medications you list are systemic medications. They require continued use and have significant side effects. OsNovum in applied locally to the affected bone via a syringe. It is a one time application to regenerate the health of the bone. Our experience in the jaw indicates the effect is long lasting as we have not seen a decline is density over time. How long the effect will be in the rest of the skeleton is unknown at this time. OsNovum has no known side effects. All the best...

OsNovum

Revolutionizing the $25B osteoporosis industry with a novel regenerative solution for weak bones

osnovum.com

Henderson, NV

Technology Female Founder B2B Healthcare B2C

What Investors Say

LEAD INVESTOR

Invested $1,001 this round + $70,000 previously

As an experienced dentist, we have been using the same bone graft materials in the jaws for over 15 years. I am excited to see this same technology used to regenerate bone from loss due to osteoporosis. This will greatly help to change the lives of millions of people. The current treatment for osteoporosis kills bone, OsNovum graft material builds strong bone and can be placed locally right where the bone loss occurs. This revolutionary treatment does not kill osteoclasts that are needed to create osteoblasts, which traditional treatments does.

What People Say

OsNovum

Quick facts

Team profiles

Featured investor profiles

What Investors Say